Early Cognitive Interventions in Digital Format for Cancer Survivors: Home-Based Training for CRCI
Official title: Early Cognitive Interventions in Digital Format for Cancer Survivors - INCOTEM
Run by Biogipuzkoa Health Research Institute · NCT07729969 · Data updated 2026-11-12
Two digital cognitive training programs done at home (one computerized, one virtual reality) are tested to see if they help adults with cancer-related cognitive changes more than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Biogipuzkoa Health Research Institute Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Bilbao, Bizkaia and 2 other locations) |
| Status | Recruiting |
| Started | June 8, 2026 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07729969 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with a cancer diagnosis (stage I–III) and self-reported cognitive difficulties within 1–6 months after chemotherapy, with internet access and Spanish literacy.
✕Probably not a fit
Participants who do not experience cognitive improvements or have adherence challenges may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares two home-based cognitive training platforms—BrainHQ (computerized exercises) and Enhance VR (virtual reality) against a control group. Adults with stage I–III cancer and subjective cognitive concerns within 1–6 months after chemotherapy are randomized to one of the two interventions or control. Interventions last 10 weeks with pre- and post-assessments to evaluate changes in cognitive function and user acceptability. The study emphasizes usability, adherence, and potential transfer of cognitive gains to daily activities.
Why it matters
Potential benefit: If successful, participants may experience improved cognitive function and better ability to resume work and daily activities.
How similar studies have gone: Prior research suggests cognitive training can help CRCI; VR-based approaches are being explored to improve engagement and real-world transfer.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age diagnosed with cancer (stage I-III) * Subjective complaints of cognitive functioning related to the diagnosis of cancer and/or cancer treatments * Between 1-6 months after completion of chemotherapy treatment * To have Wi-Fi and a computer/tablet * To sign the informed consent form Exclusion Criteria: * Previous history of cancer diagnosis * Anticipated change in cancer treatment/general medical treatment during the intervention period * Previous diagnosis of cognitive impairment * Diagnosis of other neurological or psychiatric diseases * Diagnosis of severe untreated depression * History of episodes of vertigo, epilepsy or seizures * Currently undergoing or having undergone any other type of intervention aimed at improving cognitive functioning (e.g., CRCI workshops) * Severe visual or hearing difficulties that may affect the performance of the intervention exercises * Inability to speak, understand, read, and write Spanish correctly * Failure to sign the informed consent form
Where it's running
-
Hospital Universitario Basurto
Bilbao, Bizkaia, Spain Recruiting -
Hospital Universitario Galdakao-Usansolo
Galdakao, Bizkaia, Spain Recruiting -
Hospital Universitario Donostia
San Sebastián, Gipuzkoa, Spain Recruiting
Study contacts
- Study coordinator: Dr. Ander Urruticoechea Ribate
- Email: ander.urruticoechearibate@osakidetza.eus
- Phone: +34943328000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Memantine plus structured exercise to protect thinking and memory during breast cancer chemotherapy
This will test whether memantine combined with a supervised exercise program, memantine alone, or a placebo can prevent or reduce thinking and memory problems in people receiving chemotherapy for stage I–III breast cancer.
-
Evaluating health changes in patients with Obstructive Sleep Apnea after ventilotherapy
This study is testing how three weeks of ventilotherapy affects the health, thinking skills, and overall wellbeing of people with Obstructive Sleep Apnea.
-
Examining brain changes in colorectal cancer patients undergoing chemotherapy
This study is trying to see how chemotherapy affects thinking and memory in people with colorectal cancer.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.